Sonendo® reaches “500,000 patients treated milestone” with the GentleWave® Procedure

Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, has announced that more than 500,000 patients have been treated with the GentleWave Procedure.

Sonendo’s GentleWave System ushers in the next evolution in endodontic technology that is transforming a rapidly growing number of practices across North America.

The GentleWave System uses patented, novel technology to deliver more thorough cleaning and disinfection to the entire root canal system —even in the microscopic places where bacteria can hide—and leaves more of the tooth structure intact1,2.

Most GentleWave Procedures can be performed in one visit3 and in general, patients find the procedure to be comfortable and report minimal to no pain after the procedure4. Additionally, the System releases virtually no aerosolised material into the air during normal use5, which potentially reduces the threat of spread of airborne infection – such as COVID-19 – to patients, clinicians, and their staff.

Procedure instruments for the GentleWave System also come pre-sterilised and are single use, hence minimise the risk of exposure from one patient to the next.

Bjarne Bergheim, president and CEO of Sonendo, commented, “We are grateful to the many clinicians and their staff who have supported us on this journey that has now positively impacted the lives of more than 500,000 patients.

Our innovation is always centred around the patient and it is very humbling to see the strong adoption. This landmark achievement underscores the market demand for GentleWave Procedures and further demonstrates our commitment to partner with endodontists to advance and elevate patient care.

We are also very thankful to all the employees and their families who remain steadfast in their commitment to making a difference in the lives of people and helped us reach this milestone.”

References:

  • 1. Vandrangi P et al. (2015) Oral Health 72-86
  • 2. Molina B et al. (2015) J Endod. 41:1701-05
  • 3. Sigurdsson et al. J Endod 2018; 44(3):510-517
  • 4. Sigurdsson et al. J Endod 2016; 41(7):1040-10484
  • 5. Data on file at Sonendo; internal testing report# TR20-002